在患有慢性疲劳的淋巴瘤幸存者的多维干预的可行性
Skh Bøhn1, L M Oldervoll2,3, K V Reinertsen4
1National Advisory Unit for Late Effects After Cancer Treatment, Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway. synn@ous-hf.no.
概括
多维干预改善了淋巴瘤幸存者的慢性疲劳 (CF). 该研究表明,参与者的坚持和满意度很高,大多数参与者报告了更好的疲劳,生活质量和身体表现.
科学领域:
- 在瘤学瘤学.
- 康复医学 康复医学 康复医学
- 心理学 心理学 心理学
背景情况:
- 慢性疲劳 (CF) 影响了25-30%的淋巴瘤幸存者.
- 有限的干预措施存在,以解决CF在这个人群.
研究的目的:
- 评估对患有CF的淋巴瘤幸存者的多维干预的可行性.
- 评估干预后疲劳,生活质量 (QoL) 和身体表现的变化.
主要方法:
- 一个单臂可行性研究涉及7名CF淋巴瘤幸存者.
- 12周的干预包括患者教育,运动,基于认知行为疗法 (CBT) 的计划和营养咨询.
- 通过招聘,评估完成,遵守和患者经验来评估可行性.
主要成果:
- 评估完成率高 (T0时91%;T1时83%).
- 干预的坚持率在69%至91%之间.
- 五名参与者报告说,疲劳,生活质量和身体表现有所改善;所有人都认为炼是有用的.
结论:
- 多维干预对于患有CF的淋巴瘤幸存者来说是可行的.
- 较高的坚持率和积极的参与者反表明有效性.
- 这项干预措施对减少疲劳,改善生活质量和身体表现有前途.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...